Kindstar Globalgene Technology, Inc.
HKSE: 9960.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Shiang Huang
- Employees
- 3,011
- Headquarters
- Wuhan, China
- IPO year
- 2021
- Market cap
- HK$1.2B
- Website
- https://www.kindstar.com.cn
Loading 9960…
Loading profile data…Frequently asked questions about 9960
What does Kindstar Globalgene Technology, Inc. (9960.HK) do?
Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab...
Where does 9960.HK trade?
Kindstar Globalgene Technology, Inc. (9960.HK) trades on the Hong Kong Stock Exchange.
What sector is 9960.HK in?
Kindstar Globalgene Technology, Inc. (9960.HK) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Kindstar Globalgene Technology, Inc.?
Shiang Huang is the chief executive officer of Kindstar Globalgene Technology, Inc. (9960.HK).
Where is Kindstar Globalgene Technology, Inc. headquartered?
Kindstar Globalgene Technology, Inc. is headquartered in China.
Does 9960.HK pay a dividend?
Yes — Kindstar Globalgene Technology, Inc. (9960.HK) paid a trailing twelve-month dividend of HKD 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 9960.HK go public?
Kindstar Globalgene Technology, Inc. (9960.HK) completed its initial public offering in 2021.